Massive Bio and CureMatch Partner to provide AI powered cancer treatment

Massive Bio and CureMatch announce groundbreaking partnership accessibility to Revolutionize Cancer Treatment through AI and Clinical Trial

Massive Bio, an AI-powered platform connecting patients with clinical trials and¬†CureMatch, a healthcare technology company leveraging Knowledge Representation & Reasoning (KRR) AI for precision medicine support for oncology, and have announced a transformative partnership aimed at revolutionizing cancer treatment through advanced genomics, artificial intelligence, and expansive clinical trial accessibility. Massive Bio and CureMatch will leverage […]

Dr. Kenneth J. Widder Joins Personalis Board of Directors

Dr. Kenneth J. Widder, Personalis Board of Directors

Personalis, Inc.yesterday announced that it has appointed Kenneth J. Widder, M.D., to its Board of Directors. Dr. Widder currently serves on the boards of QuidelOrtho Corporation and Evoke Pharma, Inc. and has over 40 years of experience working with biomedical companies, having previously served as a founder, director and/or CEO of Sydnexis, Inc., OrphoMed, Inc., […]

Ibex unveils Galen 3.0 Cancer Diagnostics Platform

Ibex Medical Analytics, one of the leaders in AI-powered cancer diagnostics, recently announced the launch and roll-out of Galen 3.0, a transformative solution offering new detection capabilities and a broad set of features to support pathologists in the diagnosis of multiple tissue types across various digital pathology workflows. As per the source, Galen 3.0 is […]